Biosite and Large Scale Biology to Jointly Develop Protein Chips | GenomeWeb

NEW YORK, Jan 30 – Large Scale Biology and Biosite Diagnostics have combined efforts to develop protein chips, the companies announced Tuesday.

LSBC will pay Biosite an undisclosed sum to develop antibodies for proteins contained in LSBC’s Human Protein Index and Molecular Anatomy and Pathology database, with the two companies sharing in the profits from any diagnostic or protein chip product.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.